Ahngook wins Norvasc patent suit

Published: 2009-09-29 06:58:00

Updated: 2009-09-29 06:58:00

Ahngook Pharm got more good news on September 24, as the company said the Supreme Court upheld the company's Korean patent covering the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.

The Supreme Court has ruled in favor of Ahngook in a pa...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK